Evaluation of the mechanism of action of a progestin on endometrial andenocarcinoma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000818:Animals; D004285:Dogs; D004717:Endometrium / Q000187:drug effects*; D004965:Estrogen Antagonists; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008525:Medroxyprogesterone / Q000494:pharmacology* / Q000627:therapeutic use; D012157:Mononuclear Phagocyte System / Q000187:drug effects*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D004965:Estrogen Antagonists; D007166:Immunosuppressive Agents; D008525:Medroxyprogesterone